BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36154586)

  • 1. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
    Dai X; Chen K; Xie Y
    Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
    Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
    FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
    Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
    Environ Toxicol; 2023 Jun; 38(6):1455-1465. PubMed ID: 36988233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
    Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T
    Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
    Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
    FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
    Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
    Genomics; 2023 Jan; ():110566. PubMed ID: 36690262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.
    Liu N; Zhang C; Zhang L
    Mol Biotechnol; 2023 Jul; ():. PubMed ID: 37477820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability.
    Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q
    Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
    Zheng H; Cao Z; Lv Y; Cai X
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression.
    He RZ; Jiang J; Hu X; Lei M; Li J; Luo W; Duan L; Hu Z; Mo YY; Luo DX; Peng WX
    Cancer Cell Int; 2021 Nov; 21(1):616. PubMed ID: 34809621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WTAP Mediated N6-methyladenosine RNA Modification of ELF3 Drives Cellular Senescence by Upregulating IRF8.
    Zhou L; Zhong Y; Wang F; Guo Y; Mao R; Xie H; Zhang Y; Li J
    Int J Biol Sci; 2024; 20(5):1763-1777. PubMed ID: 38481803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
    Zhang Z; Mei Y; Hou M
    Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine.
    Huang L; Shao J; Xu X; Hong W; Yu W; Zheng S; Ge X
    Cell Adh Migr; 2023 Dec; 17(1):1-13. PubMed ID: 36849408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1
    Lyu Y; Zhang Y; Wang Y; Luo Y; Ding H; Li P; Ni G
    J Immunol Res; 2022; 2022():6130806. PubMed ID: 35733918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.